The effect of 4-pentenoic acid on fatty acid oxidation.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 5767029)

Published in Biochem Biophys Res Commun on February 07, 1969

Authors

K Brendel, C F Corredor, R Bressler

Articles by these authors

A simple, versatile, nondisruptive method for the isolation of morphologically and chemically pure basement membranes from several tissues. Life Sci (1975) 2.10

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res (1997) 1.96

Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res (1995) 1.94

Biochemical basis of the sulfonylurea-induced antabuse syndrome. Diabetes (1968) 1.63

Lipid metabolism in the newborn heart. J Clin Invest (1965) 1.55

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1. Drugs (1981) 1.47

Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3. Science (1974) 1.41

Hypoglycin and hypoglycin-like compounds. Pharmacol Rev (1969) 1.41

Studies of the mechanism of the hypoglycemic action of 4-pentenoic acid. Proc Natl Acad Sci U S A (1967) 1.40

Minimal biotransformation and toxicity of desflurane in guinea pig liver slices. Anesth Analg (1991) 1.39

Ion-exchange separation and automated assay of complex mixtures of amino acids and hexosamines. Anal Biochem (1970) 1.36

pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose. J Immunol Methods (1979) 1.31

Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci (1995) 1.27

The in vitro inhibition of insulin secretion by diphenylhydantoin. J Clin Invest (1970) 1.24

Insulin treatment in diabetes. Med Clin North Am (1978) 1.23

The role of carnitine and carnitine acyltransferase in biological acetylations and fatty acid synthesis. J Biol Chem (1966) 1.21

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol (1999) 1.18

Isolated brain microvessels: a purified, metabolically active preparation from bovine cerebral cortex. Science (1974) 1.16

Ultrastructural and biochemical analyses of isolated basement membranes from kidney glomeruli and tubules and brain and retinal microvessels. J Ultrastruct Res (1978) 1.11

The mechanism of action of hypoglycin on long-chain fatty acid oxidation. Mol Pharmacol (1967) 1.08

Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J Cell Biochem Suppl (1995) 1.05

Effect of oral contraceptives on plasma clearance. Clin Pharmacol Ther (1975) 1.03

Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev (1994) 1.03

Human diabetic perineurial cell basement membrane thickening. Lab Invest (1981) 1.03

Effect of oral contraceptives on drug metabolism. Clin Pharmacol Ther (1974) 1.00

Clinical pharmacology of oral antidiabetic agents (first of two parts). N Engl J Med (1977) 0.98

Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey. Br J Clin Pharmacol (2007) 0.98

Thickened cerebral cortical capillary basement membranes in diabetics. Arch Pathol Lab Med (1982) 0.97

The effect of thyroxine on lipid and carbohdrate metabolism in the heart. J Clin Invest (1966) 0.97

Cisplatin nephrotoxicity: in vitro studies with precision-cut rabbit renal cortical slices. Toxicol Appl Pharmacol (1987) 0.96

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. Drugs (1981) 0.95

Serum insulin levels in non-ketotic hyperosmotic diabetes mellitus. Am J Med Sci (1968) 0.95

Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes (1981) 0.95

The resolution of (plus or minus)-carnitine and the synthesis of acylcarnitines. Biochim Biophys Acta (1967) 0.94

Improved methods for harvesting and counting synchronous populations of Artemia nauplii for use in developmental toxicology. Ecotoxicol Environ Saf (1983) 0.94

The characteristics of bronchial asthma among a young adult population. Chest (1995) 0.94

Preparation and composition of alveolar extracellular matrix and incorporated basement membrane. Lung (1981) 0.93

Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function. Circulation (1991) 0.93

Effects of 4-pentenoic acid on carbohydrate metabolism in pigeon liver homogenate. J Biol Chem (1969) 0.93

Properties of a pure metabolically active glomerular preparation from rat kidneys. I. Isolation. J Pharmacol Exp Ther (1973) 0.93

Dihydrocapsaicin-induced hypothermia and substance P depletion. Eur J Pharmacol (1982) 0.92

Carnitine depletion in the choline-deficient state. Biochim Biophys Acta (1967) 0.92

In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase. Biochem Pharmacol (1997) 0.92

Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J Natl Cancer Inst (1995) 0.91

The effect of deuterium ion concentration on the properties of sarcoplasmic reticulum. J Membr Biol (1974) 0.91

Detergent-extracted small-diameter vascular prostheses. J Vasc Surg (1984) 0.91

Ultrastructural studies of metabolically active isolated adult rat heart myocytes. J Mol Cell Cardiol (1978) 0.90

In vitro degradation of L-phenylalanine mustard (L-PAM). Cancer Chemother Pharmacol (1982) 0.90

Ultrastructural analyses of control and enzyme-treated isolated renal basement membranes. Anat Rec (1981) 0.89

Effect of taurine on a muscle intracellular membrane. Biochim Biophys Acta (1973) 0.89

Clinical pharmacology of oral antidiabetic agents (second of two parts). N Engl J Med (1977) 0.89

The effect of diphtheria toxin on carnitine metabolism in the heart. Biochim Biophys Acta (1965) 0.88

Properties of a pure metabolically active glomerular preparation from rat kidneys. II. Metabolism. J Pharmacol Exp Ther (1973) 0.88

Digoxin bioavailability: formulations and rates of infusions. Clin Pharmacol Ther (1976) 0.87

Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent. Diabetes (1968) 0.87

Adaptation of a gamma-glutamyl transpeptidase assay to microtiter plates. Anal Biochem (1986) 0.87

Use of precision-cut liver slices as an in vitro tool for evaluating liver function. Toxicol Pathol (1996) 0.87

The pharmacology of carnitine. Annu Rev Pharmacol Toxicol (1987) 0.87

Preparation of positional renal slices for study of cell-specific toxicity. J Pharmacol Methods (1987) 0.87

Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines. Drug Metab Dispos (1993) 0.87

Precision cut tissue slices in culture: a new tool in pharmacology. Proc West Pharmacol Soc (1987) 0.86

Homogeneous populations of Artemia nauplii and their potential use for in vitro testing in developmental toxicology. Teratog Carcinog Mutagen (1985) 0.86

Taurine and isethionic acid: distribution and interconversion in the rat. J Nutr (1972) 0.86

Efficiency of EPI cluster sampling for assessing diarrhoea and dysentery prevalence. Bull World Health Organ (1997) 0.86

The influence of ouabain and alpha angelica lactone on calcium metabolism of dog cardiac microsomes. J Clin Invest (1969) 0.86

Differential patterns of injury to the proximal tubule of renal cortical slices following in vitro exposure to mercuric chloride, potassium dichromate, or hypoxic conditions. Toxicol Appl Pharmacol (1987) 0.85

Chronic inhibition of fatty acid oxidation: new model of diastolic dysfunction. Am J Physiol (1990) 0.85

Determination and metabolism of dithiol chelating agents. VII. Biliary excretion of dithiols and their interactions with cadmium and metallothionein. Fundam Appl Toxicol (1990) 0.85

Dynamic organ culture of precision liver slices for in vitro toxicology. Life Sci (1985) 0.85

The addition of SDS to the Bradford dye-binding protein assay, a modification with increased sensitivity to collagen. J Biochem Biophys Methods (1981) 0.85

Isolation of proline and hydroxyproline from fossil bone. Life Sci (1982) 0.85

Regulation of glycogenolysis in isolated rat hepatocytes by the specific activation of type I cyclic AMP-dependent protein kinase. Mol Pharmacol (1979) 0.84

Growth hormone stimulation of fatty acid utilization by adipose tissue. Endocrinology (1967) 0.84

Dose tolerance and pharmacokinetic studies of L (+) pseudoephedrine capsules in man. Eur J Clin Pharmacol (1978) 0.84

The effect of taurine on cardiac sarcoplasmic reticulum. Life Sci (1977) 0.84

N-acetyl S-(1,2-dichlorovinyl)-L-cysteine produces a similar toxicity to S-(1,2-dichlorovinyl)-L-cysteine in rabbit renal slices: differential transport and metabolism. Toxicol Appl Pharmacol (1989) 0.83

Effect of O2 tension on the bioactivation and metabolism of aliphatic halides by primary rat-hepatocyte cultures. Xenobiotica (1984) 0.83

Effect of local anesthetics on insulin secretion by pancreas pieces. Diabetes (1971) 0.83

Relation of fatty acid oxidation tgluconeogenesis: effect of pentenoic acid. Life Sci (1968) 0.83

Cancer in the elderly: basic science and clinical aspects. Ann Intern Med (1985) 0.83

Insulin treatment of diabetes mellitus. Med Clin North Am (1971) 0.83

Human liver quality is a dominant factor in the outcome of in vitro studies. Cell Biol Toxicol (2001) 0.83

Calibration of hydrophones based on reciprocity and time delay spectrometry. IEEE Trans Ultrason Ferroelectr Freq Control (1988) 0.83

Sodium-dependent high affinity transport of taurine into rat brain synaptosomes. Proc West Pharmacol Soc (1976) 0.83

Sampling designs for xerophthalmia prevalence surveys. Int J Epidemiol (1997) 0.82

Comparative metabolism and toxicity of dichlorobenzenes in Sprague-Dawley, Fischer-344 and human liver slices. Hum Exp Toxicol (1995) 0.82

Metachromatic staining with Coomassie Brilliant Blue R-250 of the proline-rich calf thymus histone, H1. Biochim Biophys Acta (1980) 0.82

Glutathione effects on toxicity and uptake of mercuric chloride and sodium arsenite in rabbit renal cortical slices. Environ Health Perspect (1995) 0.82

Metabolic control of prevention of nephropathy by 2-tetradecylglycidate in the diabetic mouse (db/db). Diabetes (1982) 0.82

Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices. Toxicol Appl Pharmacol (1994) 0.81

Stereochemistry of the L-iditol dehydrogenase catalyzed hydrogen transfer to NAD. Biochim Biophys Acta (1974) 0.81

Valproic acid hepatotoxicity in human liver slices. Drug Chem Toxicol (1991) 0.81